RUBIUS THERAPEUTICS, INC.: cash_and_restricted_cash
| Value | {"amount": 114648000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2017-09-30) |
| Status | current |
| Entity | RUBIUS THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:29:53.831347+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1d0724bd-6faf-46ad-a9fe-f648bebfdbaf
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-18-067739Retrieved: 2026-08-19T17:29:53.831347+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001709401/cash-and-restricted-cash/2017-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1d0724bd-6faf-46ad-a9fe-f648bebfdbaf
History
- no predecessors — first report